CL2015000659A1 - Compuestos derivados de macrólidos; proceso de preparación; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de infecciones bacterianas. - Google Patents
Compuestos derivados de macrólidos; proceso de preparación; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de infecciones bacterianas.Info
- Publication number
- CL2015000659A1 CL2015000659A1 CL2015000659A CL2015000659A CL2015000659A1 CL 2015000659 A1 CL2015000659 A1 CL 2015000659A1 CL 2015000659 A CL2015000659 A CL 2015000659A CL 2015000659 A CL2015000659 A CL 2015000659A CL 2015000659 A1 CL2015000659 A1 CL 2015000659A1
- Authority
- CL
- Chile
- Prior art keywords
- macrolides
- prevention
- treatment
- pharmaceutical composition
- preparation process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1258744A FR2995605B1 (fr) | 2012-09-18 | 2012-09-18 | Derives de macrolides, leur preparation et leur application therapeutique. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015000659A1 true CL2015000659A1 (es) | 2015-07-10 |
Family
ID=47178173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015000659A CL2015000659A1 (es) | 2012-09-18 | 2015-03-17 | Compuestos derivados de macrólidos; proceso de preparación; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de infecciones bacterianas. |
Country Status (32)
Country | Link |
---|---|
US (1) | US20150210729A1 (es) |
EP (1) | EP2897970B1 (es) |
JP (1) | JP6231107B2 (es) |
KR (1) | KR20150056569A (es) |
CN (1) | CN104797588B (es) |
AU (1) | AU2013320407A1 (es) |
BR (1) | BR112015005560A2 (es) |
CA (1) | CA2884909A1 (es) |
CL (1) | CL2015000659A1 (es) |
CR (1) | CR20150160A (es) |
DK (1) | DK2897970T3 (es) |
DO (1) | DOP2015000062A (es) |
EA (1) | EA027177B1 (es) |
ES (1) | ES2598079T3 (es) |
FR (1) | FR2995605B1 (es) |
HK (1) | HK1209127A1 (es) |
HR (1) | HRP20161184T1 (es) |
HU (1) | HUE029841T2 (es) |
IL (1) | IL237593A (es) |
MA (1) | MA37999B1 (es) |
MX (1) | MX2015003503A (es) |
NZ (1) | NZ706393A (es) |
PE (1) | PE20150653A1 (es) |
PH (1) | PH12015500527B1 (es) |
PL (1) | PL2897970T3 (es) |
PT (1) | PT2897970T (es) |
SG (1) | SG11201501765YA (es) |
SI (1) | SI2897970T1 (es) |
TN (1) | TN2015000095A1 (es) |
UA (1) | UA114003C2 (es) |
WO (1) | WO2014044645A1 (es) |
ZA (1) | ZA201501597B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019020759A1 (en) | 2017-07-26 | 2019-01-31 | Sanofi | SEQUANAMYCIN MACROLIDES USEFUL IN THE TREATMENT OF TUBERCULOSIS |
WO2019020767A1 (en) | 2017-07-26 | 2019-01-31 | Sanofi | SEQUANAMYCIN MACROLIDES USEFUL IN THE TREATMENT OF TUBERCULOSIS |
WO2019020763A1 (en) | 2017-07-26 | 2019-01-31 | Sanofi | SEQUANAMYCIN MACROLIDES USEFUL IN THE TREATMENT OF TUBERCULOSIS |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3674773A (en) * | 1970-10-06 | 1972-07-04 | Abbott Lab | Erythromycin derivatives |
FR2126108B1 (es) | 1971-02-25 | 1974-08-02 | Rhone Poulenc Sa | |
CN85103264A (zh) * | 1984-04-13 | 1987-01-14 | 美国辉瑞有限公司 | 9a-氮杂-9a-高红霉素衍生物 |
US4585759A (en) * | 1985-01-22 | 1986-04-29 | Pfizer Inc. | Antibacterial derivatives of a neutral macrolide |
CA1296329C (en) * | 1986-06-06 | 1992-02-25 | Derek R. Sutherland | Macrolide compounds |
US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
JPH05117291A (ja) * | 1991-09-20 | 1993-05-14 | Yamanouchi Pharmaceut Co Ltd | 新規マクロライド誘導体 |
TW226373B (es) * | 1992-07-15 | 1994-07-11 | Pfizer | |
US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
CA2466358C (en) * | 2001-11-07 | 2010-02-09 | Aventis Pharma Deutschland Gmbh | Method for the production of desclarithromycin, and intermediate products |
GB0310980D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
CN101115764B (zh) * | 2005-02-09 | 2012-09-26 | 巴斯利尔药物股份公司 | 大环内酯类化合物 |
TW200914020A (en) | 2007-08-28 | 2009-04-01 | Lilly Co Eli | Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists |
-
2012
- 2012-09-18 FR FR1258744A patent/FR2995605B1/fr active Active
-
2013
- 2013-09-16 JP JP2015531594A patent/JP6231107B2/ja not_active Expired - Fee Related
- 2013-09-16 EA EA201590594A patent/EA027177B1/ru not_active IP Right Cessation
- 2013-09-16 HU HUE13776739A patent/HUE029841T2/en unknown
- 2013-09-16 AU AU2013320407A patent/AU2013320407A1/en not_active Abandoned
- 2013-09-16 NZ NZ706393A patent/NZ706393A/en unknown
- 2013-09-16 MX MX2015003503A patent/MX2015003503A/es unknown
- 2013-09-16 DK DK13776739.8T patent/DK2897970T3/en active
- 2013-09-16 BR BR112015005560A patent/BR112015005560A2/pt not_active IP Right Cessation
- 2013-09-16 SG SG11201501765YA patent/SG11201501765YA/en unknown
- 2013-09-16 SI SI201330326A patent/SI2897970T1/sl unknown
- 2013-09-16 CA CA2884909A patent/CA2884909A1/en not_active Withdrawn
- 2013-09-16 WO PCT/EP2013/069185 patent/WO2014044645A1/en active Application Filing
- 2013-09-16 KR KR1020157008511A patent/KR20150056569A/ko not_active Application Discontinuation
- 2013-09-16 PL PL13776739T patent/PL2897970T3/pl unknown
- 2013-09-16 CN CN201380060052.1A patent/CN104797588B/zh not_active Expired - Fee Related
- 2013-09-16 UA UAA201503646A patent/UA114003C2/uk unknown
- 2013-09-16 ES ES13776739.8T patent/ES2598079T3/es active Active
- 2013-09-16 EP EP13776739.8A patent/EP2897970B1/en not_active Not-in-force
- 2013-09-16 PE PE2015000376A patent/PE20150653A1/es not_active Application Discontinuation
- 2013-09-16 PT PT137767398T patent/PT2897970T/pt unknown
-
2015
- 2015-03-05 IL IL237593A patent/IL237593A/en not_active IP Right Cessation
- 2015-03-09 ZA ZA2015/01597A patent/ZA201501597B/en unknown
- 2015-03-11 PH PH12015500527A patent/PH12015500527B1/en unknown
- 2015-03-13 TN TNP2015000095A patent/TN2015000095A1/fr unknown
- 2015-03-16 DO DO2015000062A patent/DOP2015000062A/es unknown
- 2015-03-16 US US14/658,752 patent/US20150210729A1/en not_active Abandoned
- 2015-03-17 CL CL2015000659A patent/CL2015000659A1/es unknown
- 2015-03-20 CR CR20150160A patent/CR20150160A/es unknown
- 2015-04-12 MA MA37999A patent/MA37999B1/fr unknown
- 2015-10-06 HK HK15109737.2A patent/HK1209127A1/xx not_active IP Right Cessation
-
2016
- 2016-09-15 HR HRP20161184TT patent/HRP20161184T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2013001654A1 (es) | Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor. | |
CL2014002873A1 (es) | Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer. | |
PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
CL2015000482A1 (es) | Compuestos derivado de 6-aminoacido-heteriarildihidropirimidinas; proceso de obtención; composicion farmaceutica; y su uso para el tratamiento o profilaxis de la infección por el virus de la hepatitis b | |
CL2014001858A1 (es) | Compuestos derivados de pirrolidina-2-carboxamidas sustituidas, antagonistas de mdm2; composicion farmacetica; y su uso en el tratamiento o profilaxis del cancer. | |
CL2015001702A1 (es) | Compuestos triciclicos antivirales; composicion farmaceutica; y uso en el tratamiento de la hepatitis c. | |
CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
CL2012003723A1 (es) | Compuestos derivados de acido 2-quinolinil-acetico; composicion farmaceutica; y uso en el tratamiento del vih y sida. | |
CL2015001250A1 (es) | Compuestos derivados de triazolopirazinas, inhibidores de brd4; preparacion farmaceutica; y su uso en el tratamiento y/o la prevencion de cancer, tal como cancer de pulmon, higado, colon, cerebro, tiroides, mamas, entre otros. | |
HK1222398A1 (zh) | 治療伯克霍爾德氏菌感染症的組合物及方法 | |
CL2013002125A1 (es) | Compuestos derivados de imidazo[5,1-f][1,2,4]triazinas; composicion farmaceutica; y uso en el tratamiento del deterioro cognitivo asociado con esquizofrenia. | |
CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
CL2014000819A1 (es) | Compuestos heterociclicos derivados de etinilo, moduladores alostericos mglur5; proceso de preparacion; composicion farmaceutica; uso en la prevencion o el tratamiento de esquizofrenia, enfermedades cognitivas, sindrome de la x fragil o autismo. | |
CL2014003325A1 (es) | Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer | |
EP2928470A4 (en) | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | |
BR112015009546A2 (pt) | compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas | |
CL2014001959A1 (es) | Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer. | |
BR112013014189A2 (pt) | composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções | |
HK1208378A1 (en) | Pharmaceutical composition for the treatment of fungal infections | |
CL2014003607A1 (es) | Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer. | |
CL2012001757A1 (es) | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas. | |
CL2015000333A1 (es) | Azaheterociclos inhibidores de bir2 y/o bir3; composicion farmaceutica; y uso en el tratamiento del cancer. | |
BR112015005627A2 (pt) | composto, composição farmacêutica, uso de composto, método de tratamento e invenção. |